(HMAF) HSBC MSCI AC FAR EAST ex - Ratings and Ratios
Asian Stocks, Equity Funds, Investment Portfolios
Description: HMAF HSBC MSCI AC FAR EAST ex
The HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF USD is an exchange-traded fund (ETF) that tracks the Morningstar Asia xJpn TME NR USD index, providing investors with exposure to Asia ex-Japan equity markets. The fund is domiciled in Switzerland and has a total assets under management (AUM) of $242.73 million.
From a performance perspective, the ETF has demonstrated a positive trend, with its last price at $59.22, above its 20-day, 50-day, and 200-day simple moving averages (SMA). This suggests a potential uptrend, with the 200-day SMA indicating a longer-term bullish sentiment. The average true range (ATR) is $0.54, representing a 0.91% daily price movement, indicating moderate volatility.
To further evaluate the ETFs performance, key performance indicators (KPIs) such as tracking error, expense ratio, and dividend yield can be considered. A low tracking error would indicate that the ETF is effectively replicating the underlying index. The expense ratio, which is not provided, is also crucial in determining the funds overall cost. Additionally, the dividend yield, which can be calculated based on the ETFs historical dividend payments, can provide insight into the funds income-generating potential.
From a risk management perspective, investors can consider metrics such as beta, which measures the ETFs sensitivity to market movements, and value-at-risk (VaR), which estimates the potential loss over a specific time horizon. A thorough analysis of these KPIs can help investors make informed decisions about their investment in the HSBC MSCI AC FAR EAST ex JAPAN UCITS ETF USD.
Additional Sources for HMAF ETF
HMAF ETF Overview
Market Cap in USD | 243m |
Category | Asia ex-Japan Equity |
TER | 0.45% |
IPO / Inception | 2013-09-27 |
HMAF ETF Ratings
Growth Rating | 7.43 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 6.68 |
Analysts | - |
Fair Price Momentum | 57.42 USD |
Fair Price DCF | - |
HMAF Dividends
Currently no dividends paidHMAF Growth Ratios
Growth Correlation 3m | 96.4% |
Growth Correlation 12m | 71% |
Growth Correlation 5y | -41.7% |
CAGR 5y | 3.53% |
CAGR/Max DD 5y | 0.07 |
Sharpe Ratio 12m | -0.19 |
Alpha | 6.98 |
Beta | 0.771 |
Volatility | 19.02% |
Current Volume | 0.8k |
Average Volume 20d | 1.5k |
Stop Loss | 57.3 (-3%) |
As of July 16, 2025, the stock is trading at USD 59.10 with a total of 846 shares traded.
Over the past week, the price has changed by +1.83%, over one month by +3.61%, over three months by +21.25% and over the past year by +20.33%.
Neither. Based on ValueRay´s Analyses, HSBC MSCI AC FAR EAST ex is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 7.43 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HMAF is around 57.42 USD . This means that HMAF is currently overvalued and has a potential downside of -2.84%.
HSBC MSCI AC FAR EAST ex has no consensus analysts rating.
According to our own proprietary Forecast Model, HMAF HSBC MSCI AC FAR EAST ex will be worth about 65.3 in July 2026. The stock is currently trading at 59.10. This means that the stock has a potential upside of +10.52%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 65.3 | 10.5% |